Inhibition of Bcr-Abl in human leukemic cells with a coiled coil protein delivered by a leukemia-specific cell penetrating peptide

被引：0
|
作者：
Bruno, Benjamin J. [1 ]
Lim, Carol S. [1 ]
机构：
[1] Univ Utah, Salt Lake City, UT USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2641
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2641
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Short-term intense Bcr-Abl kinase inhibition with nilotinib is adequate to trigger cell death in BCR-ABL+ cells
    Hiwase, D. K.
    White, D. L.
    Saunders, V. A.
    Kumar, S.
    Melo, J. V.
    Hughes, T. P.
    LEUKEMIA, 2009, 23 (06) : 1205 - 1206
  • [42] Interaction of a novel signaling protein (AHI-1) with BCR-ABL modulates BCR-ABL transforming activity and imatinib response of chronic myeloid leukemia progenitor cells
    Zhao, Yuri
    Zhou, Leon
    Ringrose, Ashley
    Lin, Ann E. -J.
    Kennah, Erin
    Sheng, Guoqing
    Li, Xiao-Jiang
    Turhan, Ali
    Jiang, Xiaoyan
    BLOOD, 2007, 110 (11) : 144A - 144A
  • [43] AHI-1, a novel signaling protein, interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib sensitivity of primitive chronic myeloid leukemia cells
    Zhao, Y.
    Zhou, L.
    Ringrose, A.
    Lin, A. E.
    Turban, A. G.
    Jiang, X.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 21 - 22
  • [44] Human CD8+T cell lines specific for BCR-ABL peptides located outside the junction recognize fresh CML leukemic cells.
    Michallet, AS
    Gallot, G
    Boix, C
    Figueiredo, S
    Connan, F
    Varet, B
    Choppin, J
    Guillet, JG
    Viet, H
    Buzyn, A
    BLOOD, 2000, 96 (11) : 143A - 143A
  • [45] Inhibition of BCR-ABL signaling in imatinib sensitive and resistant chronic myelogenous leukemia and progenitor cells through small molecule-mediated BCR-ABL ubiquitination and aggresomal deposition
    Donato, Nicholas
    Sun, Hanshi
    Kapuria, Vaibhav
    Peterson, Luke
    Peng, Zhenghong
    Maxwell, David
    Bornmann, William
    Talpaz, Moshe
    CANCER RESEARCH, 2009, 69
  • [46] Transient Potent BCR-ABL Inhibition Is Sufficient to Commit Chronic Myeloid Leukemia Cells Irreversibly to Apoptosis
    Shah, Neil P.
    Kasap, Corynn
    Weier, Christopher
    Balbas, Minna
    Nicoll, John M.
    Bleickardt, Eric
    Nicaise, Claude
    Sawyers, Charles L.
    CANCER CELL, 2008, 14 (06) : 485 - 493
  • [47] Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells
    Liao, Hui-Fen
    Su, Yu-Chieh
    Zheng, Zhi-Yu
    Cai, Chang Jhih
    Hou, Ming-Hung
    Chao, K. S. Clifford
    Chen, Yu-Jen
    BIOMEDICINE & PHARMACOTHERAPY, 2012, 66 (05) : 378 - 383
  • [48] A T cell clone participating in anti-leukemic donor reactive BCR-ABL specific cytotoxic T-lymphocytes (CTL) in vitro was detected after allogeneic BMT:: Evidence that BCR-ABL peptide specific CTL may contribute to graft versus leukemia (GVL) effect.
    Furukawa, T
    Narita, M
    Takahashi, M
    Yano, T
    Sato, N
    Toba, K
    Sakaue, M
    Aizawa, Y
    BLOOD, 2003, 102 (11) : 321B - 321B
  • [49] Mechanism by which Arsenic Trioxide downregulates Bcr-Abl levels and potentiates Gleevec-induced apoptosis of Bcr-Abl positive human acute leukemia cells.
    Nimmanapalli, R
    Bali, P
    O'Bryan, E
    Kuhn, D
    Bhalla, K
    BLOOD, 2001, 98 (11) : 618A - 618A
  • [50] Mechanism by which arsenic trioxide downregulates Bcr-Abl levels and potentiates Gleevec-induced apoptosis of Bcr-Abl positive human acute leukemia cells.
    Nimmanapalli, R
    Bali, P
    O'Bryan, E
    Kuhn, D
    Valkov, N
    Sullivan, D
    Bhalla, KN
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3771S - 3771S
12345